Abstract:The ongoing pandemic of COVID-19 has aroused widespread concern around the world and poses a severe threat to public health worldwide. In this paper, the autoregressive integrated moving average (ARIMA) model was used to predict the epidemic trend of COVID-19 in mainland of China. We collected the cumulative cases, cumulative deaths, and cumulative recovery in mainland of China from January 20 to June 30, 2020, and divided the data into experimental group and test group. The ARIMA model was fitted with the experimental group data, and the optimal model was selected for prediction analysis. The predicted data were compared with the test group. The average relative errors of actual cumulative cases, deaths, recovery and predicted values in each province are between −22.32%−22.66%, −9.52%−0.08%, −8.84%−1.16, the results of the comprehensive experimental group and test group show The error of fitting and prediction is small, the degree of fitting is good, the model supports and is suitable for the prediction of the epidemic situation, which has practical guiding significance for the prevention and control of the epidemic situation. Highlights: 1. We predicted future COVID-19 occurrences in mainland of China based on ARIMA model. 2. We validated the model based on the previous outbreak data with actual data for June, 2020. 3. The measures taken by the government have contained spread of the epidemic 4. The combination of multiple models may improve the robustness of the model ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement National Natural Science Foundation of China Spatial data analysis and geoscientific calculation are used to study urban vulnerability based on microgeographic units(grant numbers: 41461035). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The COVID-19 case data comes from the National and local health and construction commission daily information release (<https://ncov.dxy.cn/>).

An Autoregressive Integrated Moving Average Model for Predicting Varicella Outbreaks - China, 2019

[Evaluation of the Effect of Varicella Outbreak Control Measures Through a Discrete Time Delay SEIR Model].

Application of Autoregressive Integrated Moving Average Model in Predicting the Reported Notifiable Communicable Diseases in China

Epidemiological analysis of varicella in Dalian from 2009 to 2019 and application of three kinds of model in prediction prevalence of varicella

[Application of ARIMA Model to Predict Number of Malaria Cases in China].

Application of ARIMA model in prediction of respiratory infectious disease

[Application of autoregressive integrated moving average model to predict and analyze the incidence trend of mumps in Jiangxi Province]

ARIMA and ARIMA-ERNN models for prediction of pertussis incidence in mainland China from 2004 to 2021

Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model

Prediction and Analysis of HIV/AIDS Incidence Based on ARIMA Model in China

Application of Auto Regressive Integrated Moving Average Model in Infectious Diseases Prediction

[The Application of Time Series Analysis in Predicting the Influenza Incidence and Early Warning].

The study on the early warning period of varicella outbreaks based on logistic differential equation model

Research about the optimal strategies for prevention and control of varicella outbreak in a school in a central city of China: based on an SEIR dynamic model

Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China

[Study on the ARIMA Model Application to Predict Echinococcosis Cases in China].

Trend prediction of COVID-19 based on ARIMA model in mainland of China

A Dynamic Compartmental Model to Explore the Optimal Strategy of Varicella Vaccination: An Epidemiological Study in Jiangsu Province, China

Application of auto regressive integrated moving average model in forecasting incidence of hepatitis E in Hubei Province

Predicting Influenza-Like Illness Trends Based on Sentinel Surveillance Data in China from 2011 to 2019: A Modelling and Comparative Study

Predicting Influenza-Like Illness Trends Based on Sentinel Surveillance Data in China from 2011 to 2019: A Modelling and Comparative Study1